Invention Grant
- Patent Title: 1C31 nanoparticles
- Patent Title (中): IC31纳米粒子
-
Application No.: US13578686Application Date: 2011-02-21
-
Publication No.: US08765148B2Publication Date: 2014-07-01
- Inventor: Benjamin Wizel , Karin Riedl , Karen Lingnau , Ursula Schlosser , Jürgen Wruss , Robert Schlegl , Michael Weber , Christoph Reinisch , Ljubomir Paucz , Christoph Klade , Jee Loon Look , Christian Ruiz , Robert Seid
- Applicant: Benjamin Wizel , Karin Riedl , Karen Lingnau , Ursula Schlosser , Jürgen Wruss , Robert Schlegl , Michael Weber , Christoph Reinisch , Ljubomir Paucz , Christoph Klade , Jee Loon Look , Christian Ruiz , Robert Seid
- Applicant Address: AT Vienna
- Assignee: Valneva Austria GmbH
- Current Assignee: Valneva Austria GmbH
- Current Assignee Address: AT Vienna
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/EP2011/052496 WO 20110221
- International Announcement: WO2011/101465 WO 20110825
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K9/14 ; A61K9/51 ; A61K39/40 ; A61K39/42
Abstract:
The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13 and wherein the peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, thereby forming a suspension, characterized in that the mean particle size of the solid particles is less than 1 μm.
Public/Granted literature
- US20120308618A1 IC31 NANOPARTICLES Public/Granted day:2012-12-06
Information query
